Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)

DRUG6 trials

Sponsors

Bayer

Conditions

Age-related Macular Degeneration (AMD)Central Retinal Vein Occlusion (CRVO)Diabetic Macular Edema (DME)Macular DegenerationMacular Edema

Phase 4

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

CompletedNCT02581995

BayerMacular Edema

Start: 2015-11-19End: 2017-08-09Updated: 2018-10-10

Unknown Phase

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

CompletedNCT02585401

BayerAge-related Macular Degeneration (AMD), Central Retinal Vein Occlusion (CRVO), Diabetic Macular Edema (DME)

Start: 2016-02-18End: 2016-05-19Updated: 2017-03-21

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

CompletedNCT02850263

BayerMacular Edema

Start: 2016-07-05End: 2020-11-23Updated: 2021-11-02

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)

CompletedNCT03411941

BayerMacular Degeneration

Start: 2018-02-28End: 2019-03-01Updated: 2019-12-05

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

CompletedNCT03470103

BayerMacular Degeneration

Start: 2018-03-28End: 2021-01-15Updated: 2021-06-25

An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies

CompletedNCT03521895

BayerMacular Degeneration

Start: 2018-05-01End: 2018-11-30Updated: 2020-01-10

Related Papers

Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.

2023-03-207 citations

Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.

2023-01-18

Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study.

2022-10-182 citations

Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study

International Journal of Retina and Vitreous2022-08-027 citations

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.

2022-04-129 citations

Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes.

2021-07-0911 citations